Cepheid

Private

#Molecular Diagnostics #Infectious Disease #Point-of-Care Testing

Molecular diagnostics company and Danaher subsidiary whose GeneXpert systems automate PCR testing for infectious disease, oncology and sexual health at the point of care. Its Xpert respiratory panel received FDA clearance in September 2026.

Company Info

Sector:Diagnostics

Headquarters:Sunnyvale, California, USA

Founded:1996

Website:www.cepheid.com/en-US.html

Clinical Development Pipeline

Xpert Respiratory Panel

Target: Multiplexed respiratory pathogen RNA/DNA

Respiratory tract infections

Preclinical

Phase 1

Phase 2

Phase 3

Approved

GeneXpert Xpert MTB/RIF Ultra

Target: M. tuberculosis DNA and rifampicin resistance

Tuberculosis

Preclinical

Phase 1

Phase 2

Phase 3

Approved

GeneXpert Xpert Xpress SARS-CoV-2/Flu/RSV

Target: SARS-CoV-2, influenza A/B, RSV

Viral respiratory infection

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Recent News

No recent news updates available for this company.

Leadership Team

Luke Maitland

Senior Vice President, Chief Commercial Officer

Charles Mwangi

Senior Vice President, Chief Financial Officer

Connie Savor, M.D.

Chief Medical Officer

Careers & Job Openings

See all open roles

Careers

See posting

Apply Now →